With Stem Cell Treatment for Retinitis Pigmentosa, Save Your Health
November 08, 2023/ 0 comment
With Stem Cell Treatment for Retinitis Pigmentosa, Save Your Health
Stem cell treatment Retinitis Pigmentosa has advanced recently. In this treatment patients with various eye problems are treated by implanting stem cells via retrobulbar or another effective route to achieve maximum retrieval and the eye stem cell center provides the best facilities for the stem cell treatment for Retinitis Pigmentosa.
Retinitis pigmentosa (RP) is a genetic eye disease that causes blindness. Among the symptoms (side vision) are night vision problems and a loss of peripheral vision. Individuals may develop “tunnel vision” as their peripheral vision deteriorates. Retinitis pigmentosa is often handed down through families. Mutations in any of the more than 50 genes can cause it. The progressive loss of rod photoreceptor cells in the rear of the eye is the underlying cause. As a result of this, photoreceptor cone cells are diminished.
Stem cell therapy is a treatment in which repaired cells or tissues are replaced by stem cells. It can be obtained by Bone Marrow Transplants, infusion directly into the circulation, or extraction from the patient’s own system for self-rejuvenation. Many ailments, including blood disorders, can be helped by stem cell treatment, such as by destroying cancer cells. In this sort of stem cell treatment, the patient will be given a high dose of medications, either alone or in combination with radiation therapy, to destroy the malignancy. The doctor would then infuse the healthy stem cells that had been obtained earlier from the donor or from the same individual when the body was healthy back into the body. These newly infused stem cells travel into the bone marrow and, over time, produce new healthy stem cells.
Stem cell treatment can help the person recover faster since healthy cells are pumped into the body and provide a large and significant benefit.
How Retinitis Pigmentosa Treated in India:
In the ongoing Phase I/II clinical trial for Retinitis Pigmentosa Treatment in India, an investigational stem cell-derived treatment targeted to preserve and maybe improve eyesight in persons with retinitis pigmentosa (RP) has exhibited a favorable safety profile. Given that this is one of the first stem-cell-derived therapies for RP, this safety data is both welcome and significant. As the experiment continues, the Foundation anticipates more findings in the coming years.
Retinitis Pigmentosa is a disorder that causes deterioration of vision and eventually blindness as you become older. It is a collection of genital diseases that can be passed down from either parent. Significant forms of RP and disorders associated with them are as follows:
Usher syndrome
Leber’s congenital amaurosis (LCA)
Rod-cone disease
Bardet-Biedl syndrome
Eye Stem Cell Center treatment facility stands as a testament to our dedication to providing the best possible care for our patients. It is equipped with cutting-edge technology and state-of-the-art equipment, ensuring that you receive the most advanced and effective treatment available. At the Eye Stem Cell Center, you can expect the best in both care and results, as it continues to lead the way in Retinitis Pigmentosa treatment.